OHB's Backlog Tops €3.3 Billion, but the Fine Print Complicates the Growth Narrative

OHB SE's H1 2026 shows strong operational growth (revenue +11%, EBITDA +31%) but Q2 net loss of €5M; backlog at €3.3B, capital raise of €484M completed.

The space sector's European champion has been making headlines for its index credentials, yet the numbers that truly matter for shareholders emerged from the half-year report published on August 6. OHB SE's operational engine is clearly accelerating — but a closer look at the bottom line reveals a more nuanced story than the headline growth figures suggest.

Revenue for the first six months of 2026 reached €627.9 million, an 11 percent improvement on the prior-year period. Adjusted EBITDA, however, sprinted ahead by 31 percent to €60.4 million, underscoring that scale effects and project utilization are translating into profitability gains at a faster clip than top-line expansion alone would indicate. The second quarter told a similar story in miniature: sales grew 7 percent to roughly €329 million, while adjusted EBITDA climbed more than a quarter to just over €33 million.

That operational vigor, though, has yet to filter through to the net result. OHB booked a net loss of approximately €5 million in the second quarter, swinging from a €7.5 million profit a year earlier. Sharply higher costs and losses on equity investments did the damage — a divergence between robust operating performance and a negative bottom line that is likely to keep investors occupied in the quarters ahead.

A Backlog Built for the Long Haul

Order visibility remains the cornerstone of the investment case. The group's order backlog expanded to €3,304 million from €3,067 million a year earlier, with management pointing to the second half of 2026 as the expected peak for order intake. Adding further ballast, OHB Italia was named prime contractor in late July for the Italian space agency ASI's PRISMA Second Generation Earth-observation mission, with the satellite slated for launch by the end of 2031. Multi-year programs of this stripe extend planning certainty well beyond the current fiscal year and reinforce the picture of a structurally expanding backlog.

The company has held firm on its 2026 guidance, projecting total output of €1,400 million with an adjusted EBITDA margin between 10.5 and 11 percent. The medium-term trajectory is more ambitious still: management targets group output exceeding €4.0 billion at a margin of roughly 13 percent. That path presupposes sustained momentum on the growth front while costs remain disciplined — a balancing act the second quarter's operating-versus-net divergence has already put into sharp relief.

Fresh Capital, Familiar Ownership

The growth agenda now has a thicker financial cushion behind it. OHB completed a €484 million capital increase in July, with net proceeds earmarked for manufacturing capacity expansion, potential acquisitions, and investments in launch vehicles and facilities. The transaction lifted the free float to approximately 18 percent, though the Fuchs family retains its controlling stake of over 60 percent.

The timing of the raise coincided with a period of heightened capital-markets activity for the group. Its unscheduled promotion to the SDAX index last Thursday drew fresh attention, though the shares have eased 1.0 percent since the announcement. The stock closed Friday at €257.00, down 1.0 percent on the day but still 10 percent higher on the week — evidence that the market has digested the half-year numbers and order growth positively, even if individual sessions have seen some give-back. The shares remain well below their 52-week high of €688.00, reached in May.

Sector Tailwinds and the Road Ahead

Beyond company-specific developments, a broader European dynamic is at play. Geopolitical shifts, rising defense budgets, and a renewed emphasis on technological sovereignty in space are widely cited as industry-wide drivers — an environment that broadly favors a European player like OHB. The combination of confirmed guidance, a swelling order book, and fresh international mandates provides the central anchor for the investment story, independent of any short-term index effect from the SDAX admission. Whether the operational momentum can eventually close the gap with the net result, however, remains the open question for the quarters ahead.